ArticleHead & neck2024

Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.

Jipei Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.